DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+35.17%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$336M
AUM Growth
+$336M
(+9.2%)
Cap. Flow
-$49.4M
Cap. Flow
% of AUM
-14.71%
Top 10 Holdings %
Top 10 Hldgs %
56.86%
Holding
90
New
10
Increased
16
Reduced
26
Closed
16
Top Buys
| 1 |
Galapagos
GLPG
|
$3.56M |
| 2 |
Cassava Sciences
SAVA
|
$3.07M |
| 3 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$2.94M |
| 4 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$2.71M |
| 5 |
Venus Concept
VERO
|
$2.6M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$22.2M |
| 2 |
Arcturus Therapeutics
ARCT
|
$9.85M |
| 3 |
Fate Therapeutics
FATE
|
$9.47M |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
$3.99M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$2.94M |
Sector Composition
| 1 | Healthcare | 89.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Cassava Sciences
SAVA
$110M
| $3.07M | 0.91% | +450,000 | New | +$3.07M |
|
|
CNST
27
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $2.9M | 0.86% | 100,594 -80,348 | -44% | -$2.31M |
|
|
HOOK
28
DELISTED
HOOKIPA Pharma
HOOK
| $2.77M | 0.83% | 250,000 +227,939 | +1,033% | +$2.53M |
|
|
KNTE
29
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $2.71M | 0.81% | +68,121 | New | +$2.71M |
|
|
30
Venus Concept
VERO
$4.11M
| $2.6M | 0.77% | +1,500,000 | New | +$2.6M |
|
31
89bio
ETNB
$1.34B
| $2.57M | 0.76% | 105,478 -5,000 | -5% | -$122K |
|
32
Viking Therapeutics
VKTX
$3.04B
| $2.57M | 0.76% | 455,900 +5,000 | +1% | +$28.2K |
|
|
OTIC
33
DELISTED
Otonomy, Inc.
OTIC
| $2.52M | 0.75% | 389,592 -299,508 | -43% | -$1.94M |
|
34
Apellis Pharmaceuticals
APLS
$3.48B
| $2.51M | 0.75% | 43,916 +13,862 | +46% | +$793K |
|
|
MREO
35
Mereo BioPharma
MREO
$272M
| $2.39M | 0.71% | 668,148 +468,723 | +235% | +$1.68M |
|
|
MORF
36
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $2.06M | 0.61% | +61,467 | New | +$2.06M |
|
|
KDMN
37
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.95M | 0.58% | 470,361 -93,203 | -17% | -$387K |
|
38
Alector
ALEC
$238M
| $1.93M | 0.57% | 127,500 -12,500 | -9% | -$189K |
|
39
Sutro Biopharma
STRO
$72.7M
| $1.85M | 0.55% | 85,000 -33,940 | -29% | -$737K |
|
40
MEI Pharma
MEIP
$160M
| $1.82M | 0.54% | 691,000 +25,000 | +4% | +$66K |
|
|
PRVL
41
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $1.73M | 0.51% | 75,000 | – | – |
|
|
NTUS
42
DELISTED
Natus Medical Inc
NTUS
| $1.72M | 0.51% | 85,575 +42,675 | +99% | +$855K |
|
43
Liquidia Corp
LQDA
$2.38B
| $1.7M | 0.5% | 575,000 | – | – |
|
|
KRTX
44
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.69M | 0.5% | 16,668 +7,437 | +81% | +$755K |
|
|
FSDC
45
DELISTED
FS Development Corp. Class A Common Stock
FSDC
| $1.65M | 0.49% | +150,000 | New | +$1.65M |
|
46
SCYNEXIS
SCYX
$34.9M
| $1.53M | 0.46% | +200,000 | New | +$1.53M |
|
47
Johnson & Johnson
JNJ
$427B
| $1.48M | 0.44% | 9,400 | – | – |
|
|
ALPN
48
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $1.43M | 0.42% | 113,202 -35,058 | -24% | -$442K |
|
|
HARP
49
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.41M | 0.42% | 85,119 | – | – |
|
50
Compugen
CGEN
$132M
| $1.4M | 0.42% | 115,202 | – | – |
|